Accessibility Tools
Advanced organ-on-chip systems strive to replicate human physiology more closely than traditional culture models. However, without comprehending the oxygen levels experienced by cells, the picture remains incomplete. In our latest webinar, we are delighted to introduce the DynamicOrgan® O2-Sensor Kit, developed by Dynamic42 in collaboration with PyroScience.
Our latest webinar unveils the DynamicOrgan TME-Kit for cancer research, enabling biomimetic matrix integration in 3-channel biochips for advanced cancer models.
This webinar explores modelling the tumour microenvironment of pancreatic cancer using a vascularised spheroid-on-chip model. Researchers will present data on the success of vorinostat in reducing tumour cell viability in this model.
This webinar introduces organ-on-a-chip (OoC), a technology that overcomes the limits of 2D cultures and animal models by recreating human tissue environments in vitro.
Instead of hosting yet another “Introduction to…” this webinar is a detailed step-by-step guide on how to develop your own organ model once getting started in the lab.
In this webinar, speakers from MPSlabs and Dynamic42 will speak about the organ-on-chip platform and interactive computational software developed to understand whether small molecules can cross the blood-placenta-barrier in pregnant women.
This webinar talks about TEER in organ-on-chip, as non-invasive method for measuring electrical resistance to monitor cell and tissue barriers. Our new organ-on-chip platform enables real-time monitoring of viability and tissue integrity using TEER measurements.
In the NATworks webinar, 8 companies introduce themselves, each helping to replace animal testing with state-of-the-art technologies and innovative research. They provide information about career opportunities in the industry for those who want to work in a humane and cruelty-free manner. The webinar is aimed at students, graduates and anyone interested in pioneering animal-free methods.
Webinar on HepaRG™ model from Biopredic including a talk by our CEO Dr. Knut Rennert on our HepaRG™-based microphysiological human liver model.
Webinar on compound adsorption by different biochip materials and the consequences on preclinical research.